In glioma-initiating cells (GICs), Hh signaling regulated SOX2 expression by helping Gli2 bind to the SOX2 promoter, and this pathway as well as GIC properties was mitigated by knock-down of urokinase receptor (uPAR) and cathepsin B 48. Here, SOX2 is linked to central nervous system cancer.